A phase I study of gemcitabine, capecitabine, and vandetanib in patients with advanced solid tumors with an expanded cohort in biliary and pancreatic malignancies

被引：0
|
作者：
Nallapareddy, S.
Eckhardt, S. G.
O'Bryant, C. L.
Eppers, S.
Diab, S.
Kane, M. A.
Weekes, C. D.
Spratlin, J. L.
Messersmith, W. A.
Leong, S.
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
[2] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.2535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2535
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies
    Maarten J. Deenen
    Heinz-Josef Klümpen
    Dick J. Richel
    Rolf W. Sparidans
    Mariette J. Weterman
    Jos H. Beijnen
    Jan H. M. Schellens
    Johanna W. Wilmink
    Investigational New Drugs, 2012, 30 : 1557 - 1565
  • [42] Phase I and pharmacokinetic study of the oral fluoropyrimidine capecitabine in combination with paclitaxel in patients with advanced solid malignancies
    Villalona-Calero, MA
    Weiss, GR
    Burris, HA
    Kraynak, M
    Rodrigues, G
    Drengler, RL
    Eckhardt, SG
    Reigner, B
    Moczygemba, J
    Burger, HU
    Griffin, T
    Von Hoff, DD
    Rowinsky, EK
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1915 - 1925
  • [43] Phase II study of gemcitabine, capecitabine and cisplatin in patients with advanced pancreatic cancer.
    Chang, HM
    Kim, TW
    Ahn, JH
    Ryu, MH
    Lee, JS
    Kim, WK
    Kang, YK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 368S - 368S
  • [44] Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors
    Rangwala, Fatima
    Bendell, Johanna C.
    Kozloff, Mark F.
    Arrowood, Christy C.
    Dellinger, Andrew
    Meadows, Jennifer
    Tourt-Uhlig, Sandra
    Murphy, Jennifer
    Meadows, Kellen L.
    Starr, Aijing
    Broderick, Samuel
    Brady, John C.
    Cushman, Stephanie M.
    Morse, Michael A.
    Uronis, Hope E.
    Hsu, S. David
    Zafar, S. Yousuf
    Wallace, James
    Starodub, Alexander N.
    Strickler, John H.
    Pang, Herbert
    Nixon, Andrew B.
    Hurwitz, Herbert I.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 700 - 709
  • [45] A Phase I Study of Capecitabine, Oxaliplatin, and Lapatinib in Metastatic or Advanced Solid Tumors
    Dennie, Trevor W.
    Fleming, Ronald A.
    Bowen, Carolyn J.
    Dar, Mohammed M.
    Alberti, Dona
    Oliver, Katherine
    Loconte, Noelle
    Mulkerin, Dan
    Holen, Kyle D.
    CLINICAL COLORECTAL CANCER, 2011, 10 (01) : 57 - 62
  • [46] Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors
    Fatima Rangwala
    Johanna C. Bendell
    Mark F. Kozloff
    Christy C. Arrowood
    Andrew Dellinger
    Jennifer Meadows
    Sandra Tourt-Uhlig
    Jennifer Murphy
    Kellen L. Meadows
    Aijing Starr
    Samuel Broderick
    John C. Brady
    Stephanie M. Cushman
    Michael A. Morse
    Hope E. Uronis
    S. David Hsu
    S. Yousuf Zafar
    James Wallace
    Alexander N. Starodub
    John H. Strickler
    Herbert Pang
    Andrew B. Nixon
    Herbert I. Hurwitz
    Investigational New Drugs, 2014, 32 : 700 - 709
  • [47] Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report
    Mavroudis, D
    Kourousis, C
    Kakolyris, S
    Agelaki, S
    Kalbakis, K
    Androulakis, N
    Souglakos, J
    Vardakis, N
    Samonis, G
    Georgoulias, V
    SEMINARS IN ONCOLOGY, 2000, 27 (01) : 25 - 30
  • [48] A phase I clinical study of biweekly pemetrexed and gemcitabine in patients with advanced solid tumors.
    Dudek, A
    Larson, T
    Mellskog, CE
    Bloss, LP
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 162S - 162S
  • [49] Phase I study of E7389/gemcitabine combination in patients with advanced solid tumors
    Goel, R.
    Chen, E.
    Welch, S.
    Laurie, S.
    Siu, L.
    Jonker, D.
    Srinivasan, R.
    Wang, L.
    Ivy, P.
    Oza, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] NCCAM/NCI phase I study of mistletoe extract and gemcitabine in patients with advanced solid tumors
    Mansky, P. J.
    Wallerstedt, D. B.
    Sannes, T.
    Stagl, J.
    Johnson, L.
    Blackman, M. R.
    Grem, J. L.
    Swain, S. M.
    Monahan, B. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345